Positron emission tomography (PET) constitutes a major advance in the diagnosis, staging,
prognostic assessment, and follow-up of lung cancer. However, it is not a magic bullet that …

Positron emission tomography (PET) imaging using 18F-2-deoxy-D-glucose, a D-glucose
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …

Publisher Summary This chapter describes the use of positron emission tomography (PET)
in clinical practice. PET is an advanced diagnostic imaging technique, which can not only …

Growing knowledge of the molecular mechanisms of oncological disease plays a key role in
the improvement of prevention, diagnosis and treatment of malignant tumors. In this review …

INTRODUCTION: Positron emission tomography (PET) now plays a clear role in oncology,
especially in chest tumours. We discuss the value of metabolic imaging in characterising …

Despite the world-wide drive to increase awareness of the risks of smoking, lung cancer
remains a global problem. A multidisciplinary team approach is now considered the most …

An estimated 180,000 new cases of lung cancer will be diag nosed in the US this year, and
lung cancer accounts for approximately 25% of all cancer deaths. Most lung cancers are …

Introduction: In this study, we evaluated the use and the contribution of
radiopharmaceuticals to the field of lung neoplasms imaging using positron emission …

The purpose of the review is to:(a) provide information concerning the physiology of lung
cancer imaging with fluorodeoxyglucose (FDG) positron emission tomography (PET)(b) …

The additional benefit of positron emission tomography (PET) in the initial staging of non-
small cell lung cancer (NSCLC) has generated interest in 18F-fluorodeoxyglucose (FDG) …